Table 1 The correlations between circARHGAP12 and cervical cancer patients’ clinicopathological characteristics.

From: IGF2BP2-modified circular RNA circARHGAP12 promotes cervical cancer progression by interacting m6A/FOXM1 manner

 

N (48)

circARHGAP12

p

Low (24)

High (24)

 

Age

<45 year

22

10

12

0.415

≥45 year

26

14

12

 

Tumor size

<4 cm

21

14

7

0.013*

≥4 cm

27

10

17

 

FIGO stages

I/II

25

12

13

0.247

III/IV

23

12

11

 

Tumor differentiation

Well/moderate

30

11

19

0.153

Poor

18

13

5

 

Lymph node metastasis

Positive

17

10

7

0.139

Negative

31

14

17

 
  1. *indicate the p < 0.05.